BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7682680)

  • 1. Formalin-induced nociceptive responses in diabetic mice.
    Kamei J; Hitosugi H; Kasuya Y
    Neurosci Lett; 1993 Jan; 149(2):161-4. PubMed ID: 7682680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
    Kamei J; Kashiwazaki T; Hitosugi H; Nagase H
    Eur J Pharmacol; 1997 May; 326(1):31-6. PubMed ID: 9178652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algogenic mediator-induced nociceptive response in diabetic mice.
    Kamei J; Kashiwazaki T; Taki K; Hitosugi H; Nagase H
    Eur J Pharmacol; 1999 Mar; 369(3):319-23. PubMed ID: 10225369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-opiod receptor-mediated forced swimming stress-induced antinociception in the formalin test.
    Kamei J; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Psychopharmacology (Berl); 1993; 113(1):15-8. PubMed ID: 7862822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the formalin-induced nociceptive response by diabetes: possible involvement of intracellular calcium.
    Kamei J; Taki K; Ohsawa M; Hitosugi H
    Brain Res; 2000 Apr; 862(1-2):257-61. PubMed ID: 10799695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
    Wu HE; Hung KC; Mizoguchi H; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):647-54. PubMed ID: 11805228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mexiletine on formalin-induced nociceptive responses in mice.
    Kamei J; Hitosugi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):153-62. PubMed ID: 7686682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptive responses to intrathecally administered substance P and somatostatin in diabetic mice.
    Kamei J; Hitosugi H; Kasuya Y
    Life Sci; 1993; 52(4):PL31-6. PubMed ID: 7678435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the formalin-induced nociceptive response by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kashiwazaki T; Kamei J
    Brain Res; 1998 Aug; 803(1-2):198-203. PubMed ID: 9729382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of substance P1-7 amide on nociceptive threshold in diabetic mice.
    Ohsawa M; Carlsson A; Asato M; Koizumi T; Nakanishi Y; Fransson R; Sandström A; Hallberg M; Nyberg F; Kamei J
    Peptides; 2011 Jan; 32(1):93-8. PubMed ID: 20933559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of spinal cholera toxin- and pertussis toxin-sensitive G proteins in nociceptive responses caused by formalin, capsaicin, and substance P in mice.
    Chung KM; Lee KC; Choi SS; Suh HW
    Brain Res Bull; 2001 Mar; 54(5):537-42. PubMed ID: 11397545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
    Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of opioid receptors in the antinociception produced by intracerebroventricularly administered spantide in mice.
    Tan-No K; Sakurada T; Yamada T; Sakurada S; Kisara K
    Neuropeptides; 1995 Nov; 29(5):293-9. PubMed ID: 8587665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effect of L-arginine in diabetic mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Mar; 254(1-2):113-7. PubMed ID: 8206107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mexiletine on algogenic mediator-induced nociceptive responses in mice.
    Hitosugi H; Kashiwazaki T; Ohsawa M; Kamei J
    Methods Find Exp Clin Pharmacol; 1999; 21(6):409-13. PubMed ID: 10445233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
    Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Kasuya Y; Nagase H; Okutomi T; Soma G; Mizuno D
    Eur J Pharmacol; 1994 Jan; 251(1):95-8. PubMed ID: 8137875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diabetes on the antinociceptive effect of beta-endorphin.
    Kamei J; Kawashima N; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Brain Res; 1993 Aug; 619(1-2):76-80. PubMed ID: 8374794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.